Transplantační medicína

 La lysoGb3 es un marcador sensible para confirmar el diagnóstico de Fabry, diferenciar fenotipos y apoyar la interpretación de variantes genéticas inciertas, complementando pruebas enzimáticas y genéticas.

During the BR1DGE Talks symposium at EASD 2025, experts discussed learnings from the implementation of population-level type 1 diabetes (T1D) screening programs.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.  

During the BR1DGE Symposium at the European Association for the Study of Diabetes (EASD) 2025 congress titled “A New Dawn in T1D: How Early Screening and Intervention Could Light the Way to Improved Clinical Outcomes”, experts discussed the importance of early detection in the management of autoimmune type 1 diabetes (T1D), risk factors for T1D, and different investigational therapeutic strategies in Stage 3 T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.